The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares
Keyword results: clinical trial
IXICO – “contract win”. Is it?, and what about the contract loss and financial outlook?
Medical analytics company IXICO plc (IXI) has announced that it “has been selected by a leading global pharmaceutical company, and new client, to provide MRI imaging services for an early phase clinical trial”. So what’s the detail, with the shares currently up approaching 4% at 26.5p in response?- By Steve Moore
- 295 days ago
Complete Coverage
Recent Comments
Time left: 16:33:31